Abivax S.A.
ABVXNasdaqHealthcare · Pharmaceutical Preparations · I0 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Sofinnova Crossover IActivist (13D)May 11, 2026
- Invus Global Management, LlcPassive (13G)Feb 13, 2026
- Venrock Healthcare Capital Partners Iii, L.P.Passive (13G)Nov 14, 2025
- Tcg Crossover Gp I, LlcPassive (13G)Nov 14, 2025
- Deep Track Capital, LpPassive (13G)Aug 14, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 2.5M | 3.0 | -2.6% |
| Apr 30, 2026 | 2.5M | 3.1 | -0.6% |
| Apr 15, 2026 | 2.6M | 3.0 | -21.6% |
| Mar 31, 2026 | 3.3M | 2.7 | -1.5% |
| Mar 13, 2026 | 3.3M | 3.7 | +1.5% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Recent SEC filings
All filings ↗- 6-KMay 22, 2026
- 6-KMay 20, 2026
- SCHEDULE 13D/AMay 11, 2026
- 6-KMay 7, 2026
- 424B7May 7, 2026
- 6-KApr 20, 2026
- S-8Mar 23, 2026
- 20-FMar 23, 2026
- 6-KMar 23, 2026
- 6-KFeb 23, 2026
- SCHEDULE 13G/AFeb 13, 2026
- SCHEDULE 13D/AJan 14, 2026
- 144Jan 8, 2026
- 6-KDec 15, 2025
- SCHEDULE 13G/ANov 14, 2025
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.